Mutations in TRPML1 result in MLIV, a neurodegenerative disease first recognized in 1974 [150], with phenotypes including mental disability, motoric dysfunction, retinal degeneration and shortened lifespan [151]. Here, MCOLN1 is linked to neurodegenerative disease.